STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)																	12 Months Ended
	Sep. 03, 2021	Jun. 21, 2021	May 28, 2021	May 26, 2021	Feb. 04, 2021	Jan. 19, 2021	Oct. 16, 2020	Sep. 23, 2020	Aug. 21, 2020	Aug. 18, 2020	Jul. 28, 2020	Jul. 07, 2020	Jun. 04, 2020	May 15, 2020	Apr. 03, 2020	Feb. 20, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 09, 2019	Nov. 02, 2019	Oct. 31, 2017	Jun. 20, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value																	$ 0.02	$ 0.02
Purchase price per share																					$ 0.15
Preferred Stock, Shares Authorized																	47,000	47,000
Preferred Stock, Par or Stated Value Per Share																	$ 0.02	$ 0.02
Preferred stock liquidation per share																	$ 1,000
Preferred stock liquidation value																	$ 43,000,000
Investments																	$ 4,341,000	$ 1,056,000
Debt Instrument, Redemption, Description																	In addition, on the first day of each calendar year, for a period of not more than ten (10) years, commencing January 1, 2021, or the first business day of the calendar year if the first day of the calendar year falls on a Saturday or Sunday, the shares available under this plan will automatically increase in an amount equal to the lesser of (i) five percent (5%) of the total number of shares of Common Stock outstanding as of December 31 of the preceding fiscal year or (ii) such number of shares of Common Stock as determined by the Board of Directors.
Share-based Payment Arrangement, Expense																	$ 46,000	$ 188,000
Earnings Per Share, Basic																	$ 0.01	$ 0.05
Earnings Per Share, Diluted																		$ 0.03
Issuance of common stock, net																	$ 121,780,000	$ 20,195,000
Share based compensation																	78,000	156,000
Share-based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fair value of options vested during the year																	$ 2,000	$ 100,000
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Acquisition of American Pacific Bancorp, shares																	47,000
Preferred stock liquidation value										$ 1,000
Impact BioMedical, Inc. [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value									$ 0.02
Purchase price per share									$ 6.48
Preferred Stock, Par or Stated Value Per Share										$ 0.02
Acquisition of American Pacific Bancorp, shares									483,334
Conversion of stock description										A Preferred Stock has the option to convert each share of Series A Preferred Stock into a number of common shares in the Company equal to the $1,000 liquidation preference divided by a conversion price of $6.48 or 154.32 shares subject to a Beneficial Ownership Limitation of 19.99%, as defined in the Share Exchange Agreement.
Impact BioMedical, Inc. [Member] | Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred Stock, Shares Authorized										47,000
Acquisition of American Pacific Bancorp, shares							662,500
Preferred stock liquidation per share										$ 1,000
Preferred stock liquidation value										$ 46,868,000
Conversion shares							4,293
Issuance of common stock, net									$ 46,868,000
Global BioMedical Pte Ltd [Member] | Series A Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion shares		7,259	35,316
Global BioMedical Pte Ltd [Member] | Common Class A [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion shares		1,120,170	5,450,000
Investor Relations Firm [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation																	$ 105,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares	12,156,000																67,340,000	3,434,000
Acquisition of American Pacific Bancorp, shares
Conversion shares																		7,233,000
Issuance of common stock, net																	$ 1,347,000	$ 68,000
Common Stock [Member] | Impact BioMedical, Inc. [Member] | Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion shares										7,232,670
Mr. Heng Fai Ambrose Chan [Member] | LiquidValue Development Pte Ltd [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price																				$ 7.80
Management [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares restricted stock issued															5,833
Stock Issued During Period, Value, Restricted Stock Award, Gross																		$ 38,000
Board of Directors Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price															$ 6.60
Shares restricted stock issued															5,800
Shares vested															8,900
Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares													21,000
Issuance of common stock, net													$ 210,000
Chief Executive Officer and the Chairman of the Board [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price								$ 4.48
Shares vested								20,000
Underwriting Agreement [Member] | Underwriter [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from net offering												$ 6,700,000		$ 6,200,000		$ 4,000,000
Underwriting Agreement [Member] | Underwriter [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares											453,333	1,028,800		769,230		740,741
Common stock, par value											$ 0.02	$ 0.02				$ 0.02
Purchase price per share											$ 7.50	$ 6.25				5.40
Pre-reverse stock split per share																$ 0.18
Underwriting Agreement [Member] | Underwriter [Member] | Additional Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares											38,533	154,320		115,384		111,111
Underwriting Agreement [Member] | Mr. Heng Fai Ambrose Chan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from net offering																$ 2,000,000
Jan. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares						6,666,666
Common stock, par value						$ 0.02
Purchase price per share						$ 3.60
Proceeds from net offering						$ 24,000,000.0
Jan. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options to purchase additional shares						1,000,000
Feb. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares					12,319,346
Common stock, par value					$ 0.02
Purchase price per share					$ 2.80
Proceeds from net offering					$ 39,700,000
Feb. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options to purchase additional shares					1,847,901
May. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock, net, shares				29,000,000
Common stock, par value				$ 0.02
Purchase price per share				$ 1.50
Proceeds from net offering				$ 45,750,000
May. 2021 Underwriting Agreement [Member] | Aegis Capital Corp [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options to purchase additional shares				4,350,000
A E I Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value	$ 0.02
Purchase price per share	$ 1.234
Investments	$ 15,000,000
2013 Plan [Member] | Share-based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorized shares																						50,000
2020 Plan [Member] | Share-based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorized shares																			241,204
2021 Plan [Member] | Share-based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorized shares																	483,125